Motility Enhancement by Tumor-Derived Mutant E-Cadherin Is Sensitive to Treatment with Epidermal Growth Factor Receptor and Phosphatidylinositol 3-Kinase Inhibitors

Author: Fuchs M.   Hutzler P.   Brunner I.   Schlegel J.   Mages J.   Reuning U.   Hapke S.   Duyster J.   Hirohashi S.   Genda T.   Sakamoto M.   Uberall F.   Hofler H.   Becker K.-F.   Luber B.  

Publisher: Elsevier

ISSN: 0014-4827

Source: Experimental Cell Research, Vol.276, Iss.2, 2002-06, pp. : 129-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content